TAMPA, FL., June 6, 2024 — Verséa Health, Inc. (“Verséa”), a Florida-based transformative health care company specializing in the commercialization of innovative diagnostics, therapeutics, and health services, has successfully acquired the ISO 9001 certification. Securing ISO 9001 certification across all three Verséa Health’s strategic business units – Diagnostics, Ophthalmics, and Discovery – represents a substantial accomplishment....
MASON, OH and TAMPA, FL., April 3, 2024 — West Point Optical Group, LLC (“WPOG”), providing quality patient care by developing experienced, well-rounded vision health teams within its 86 Pearle Vision stores, and Verséa Ophthalmics, Inc. (“Verséa Ophthalmics”), a Tampa, FL-based company that focuses on providing complete ocular point-of-care diagnostic and therapeutic interventions, today announced...
TAMPA, FL. and FLORHAM PARK, N.J., July 27, 2023 — Verséa Ophthalmics, LLC (“Verséa Ophthalmics”), a Tampa, FL-based company that focuses on providing complete ocular point-of-care diagnostic and therapeutic interventions, and Celularity Inc. (Nasdaq: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, today announced that the companies have entered into...
© 2024 Verséa Health, Inc. All rights reserved.